RD

Ravindra Deoram Suryawanshi

Active Director Director DIN 08788903
DIN 08788903 First appointment Jul 2020 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2020
Shareholding value •••• Premium profile

About Ravindra Deoram Suryawanshi

Data last updated:

Ravindra Deoram Suryawanshi is a Director at Revarthak Biopharma Private Limited (since 2020). The company operates in Chemicals. Revarthak Biopharma Private Limited reported revenue of ₹3.9 Lakh (FY 2025).

DIN 08788903
Primary Designation Director
Industry Chemicals
First Appointment 10 Jul 2020
Oldest Company Age 6 yrs
Largest company Revarthak Biopharma Private Limited · ₹3.9 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Revarthak Biopharma Private Limited U24230PN2020PTC191866
Director10 Jul 20202020₹3.9 Lakh (FY 2025)Active

Board colleagues of Ravindra Deoram Suryawanshi

Directorship timeline

Open interactive timeline →
Revarthak Biopharma Private Limited
Premium access

Shareholding and investment profile for Ravindra Deoram Suryawanshi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ravindra Deoram Suryawanshi

Ravindra Deoram Suryawanshi currently holds 1 directorship: Revarthak Biopharma Private Limited (Director, since 10 Jul 2020, revenue ₹3.9 Lakh (FY 2025)).

Ravindra Deoram Suryawanshi was first appointed on 10 Jul 2020 as Director at Revarthak Biopharma Private Limited.

The current boards of Ravindra Deoram Suryawanshi's companies include Hemant Ravindra Suryavanshi (Revarthak Biopharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available